168 related articles for article (PubMed ID: 2568983)
1. Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line.
Sugawara I; Mizumoto K; Ohkochi E; Hamada H; Tsuruo T; Mori S
Jpn J Cancer Res; 1989 May; 80(5):469-74. PubMed ID: 2568983
[TBL] [Abstract][Full Text] [Related]
2. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
[TBL] [Abstract][Full Text] [Related]
3. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.
Hamada H; Okochi E; Oh-hara T; Tsuruo T
Cancer Res; 1988 Jun; 48(11):3173-8. PubMed ID: 3365700
[TBL] [Abstract][Full Text] [Related]
4. Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice.
Li GY; Liu JZ; Zhang B; Yang M; Chen SG; Hou M; Wang LX
Adv Med Sci; 2013; 58(1):112-7. PubMed ID: 23729583
[TBL] [Abstract][Full Text] [Related]
5. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
[TBL] [Abstract][Full Text] [Related]
7. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
8. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
9. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
[TBL] [Abstract][Full Text] [Related]
10. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
Natazuka T
Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
[TBL] [Abstract][Full Text] [Related]
11. Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein.
Sun Y; Liu W; Wang C; Meng Q; Liu Z; Huo X; Yang X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2019 Apr; 234(4):3685-3696. PubMed ID: 30171603
[TBL] [Abstract][Full Text] [Related]
12. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
Ma X; Zhou X; Qu H; Ma Y; Yue Z; Shang W; Wang P; Xie S; Li Y; Sun Y
Oncol Rep; 2018 Apr; 39(4):1910-1918. PubMed ID: 29436678
[TBL] [Abstract][Full Text] [Related]
13. Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in adriamycin-resistant cancer cell lines.
Sugawara I; Ohkochi E; Hamada H; Tsuruo T; Mori S
Jpn J Cancer Res; 1988 Oct; 79(10):1101-10. PubMed ID: 2904427
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line.
Takeda Y; Nishio K; Niitani H; Saijo N
Int J Cancer; 1994 Apr; 57(2):229-39. PubMed ID: 7908894
[TBL] [Abstract][Full Text] [Related]
15. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
16. Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody.
Meyers MB; Schneider KA; Spengler BA; Chang TD; Biedler JL
Biochem Pharmacol; 1987 Jul; 36(14):2373-80. PubMed ID: 3606647
[TBL] [Abstract][Full Text] [Related]
17. Association of sorcin with drug resistance in L1210 cells.
Roberts D; Meyers MB; Biedler JL; Wiggins LG
Cancer Chemother Pharmacol; 1989; 23(1):19-25. PubMed ID: 2909286
[TBL] [Abstract][Full Text] [Related]
18. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.
Kuwazuru Y; Yoshimura A; Hanada S; Ichikawa M; Saito T; Uozumi K; Utsunomiya A; Arima T; Akiyama S
Br J Haematol; 1990 Jan; 74(1):24-9. PubMed ID: 1968762
[TBL] [Abstract][Full Text] [Related]
19. SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells.
Kudo N; Kouno R; Shibayama Y
Biol Pharm Bull; 2023 Sep; 46(9):1304-1309. PubMed ID: 37407483
[TBL] [Abstract][Full Text] [Related]
20. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
